According to analysts at Jefferies, legislation such as the newly proposed bills that aim to streamline regulatory processes ...

Despite this promising run, however, funding in the cyclical biotech industry declined over the last year, causing Medpace's ...

This growth shows the sector’s resilience ... With advances in CRISPR gene editing and cell therapies, biotech companies are addressing medical needs in ways unimaginable just ten years ago.

Biotech companies make some of the best growth stocks. These firms are at the forefront of medical advances such as gene ...

It’s a problem that has stumped the medical ... in biotech innovation. On the business side, Heshmatpour, the Executive Chairman of NeOnc, is leading the charge with a purposeful growth strategy.

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Compass Therapeutics, Inc.